Page last updated: 2024-09-04

cyc 202 and Thyroid Neoplasms

cyc 202 has been researched along with Thyroid Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alfano, S; Festa, M; Parente, L; Petrella, A	1

Other Studies

1 other study(ies) available for cyc 202 and Thyroid Neoplasms

Article	Year
R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway. International journal of cancer, 2009, Jun-01, Volume: 124, Issue:11 Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma; Caspase 3; Cell Division; Cell Line, Tumor; G2 Phase; Humans; I-kappa B Kinase; NF-kappa B; Purines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Roscovitine; Signal Transduction; Thyroid Neoplasms; TNF-Related Apoptosis-Inducing Ligand	2009

Article

Year

R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.

International journal of cancer, 2009, Jun-01, Volume: 124, Issue:11

Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma; Caspase 3; Cell Division; Cell Line, Tumor; G2 Phase; Humans; I-kappa B Kinase; NF-kappa B; Purines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Roscovitine; Signal Transduction; Thyroid Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2009